Gastroparesis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You can be male or female.
- You must be between 12 and 21 years old.
- You have symptoms related to acid reflux (GERD) — such as ongoing inflammation of the esophagus, heartburn, throat or breathing problems — or digestive issues like nausea, vomiting, severe indigestion, or long-term constipation that have not improved with standard treatments.
- You must have had a thorough medical evaluation to rule out other possible causes of your symptoms.
- You (and/or your parent or guardian) must have signed a consent form confirming you understand the possible risks of the study drug, domperidone, including effects on hormone levels, movement-related side effects, breast changes, heart rhythm changes, and possible interactions with certain medications or herbal supplements.
Who may not be able to join:
- You have a history of, or currently have, certain heart rhythm problems, such as ventricular tachycardia, ventricular fibrillation, or a condition called Torsade des Pointes (minor irregular heartbeats may not automatically disqualify you — confirm with trial site).
- You have a significantly slow heart rate, problems with the heart's natural pacemaker, or a condition where electrical signals in the heart are blocked, or your heart's electrical timing measurement (QTc) is too long (over 450ms for males or over 470ms for females).
- You have a significant imbalance of important minerals or chemicals in your blood (confirm with trial site).
- You have bleeding in your digestive tract or a blockage in your digestive system.
- You have a type of pituitary gland tumor that produces too much of the hormone prolactin.
- You are pregnant or currently breastfeeding.
- You have a known allergy to the study drug, domperidone.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jose Cocjin, MD, Children's Mercy Hospital Kansas City
Phone: 816-302-3076
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in disease severity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.